Daratumumab-SC for Highly Sensitized Patients Awaiting Heart Transplantation
Condition(s):Allosensitization; Heart Transplant Failure and RejectionLast Updated:March 25, 2024Completed
Hide Studies Not Open or Pending
Condition(s):Allosensitization; Heart Transplant Failure and RejectionLast Updated:March 25, 2024Completed
Condition(s):AL AmyloidosisLast Updated:May 7, 2021Completed
Condition(s):Plasma Cell MyelomaLast Updated:September 9, 2019Completed
Condition(s):Multiple MyelomaLast Updated:March 23, 2018Unknown status
Condition(s):Multiple MyelomaLast Updated:March 27, 2020Withdrawn
Condition(s):T-Lymphocytic Leukemia, AcuteLast Updated:February 12, 2024Not yet recruiting
Condition(s):Systemic Lupus ErythematosusLast Updated:March 23, 2021Unknown status
Condition(s):Lupus NephritisLast Updated:June 15, 2023Recruiting
Condition(s):Myeloma MultipleLast Updated:June 20, 2019Unknown status
Condition(s):Autoimmune DisordersLast Updated:March 12, 2024Recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.